Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Krish Subramanyam of Altamount Capital advises buying Alembic with a target of Rs 50.50.
Krish Subramanyam of Altamount Capital advises buying HCL Infosystems with a target of Rs 66.
Krish Subramanyam of Altamount Capital is of the view that one may buy Sun TV Network, Indraprastha Gas, NELCO and Granules India.
Sameet Chavan of Angel Broking is of the view that above Rs 165, Granules India may hit Rs 178-180.
Prakash Gaba, Technical Analyst at prakashgaba.com feels that Granules India may touch Rs 165.
Vishal Malkan of malkansview.com advises buying Jubilant Life Sciences with a target of Rs 470.
Rakesh Bansal of RK Global is of the view that one can buy Lupin at around Rs 1650 and feels that Granules India, Sun Pharmaceutical Industries and Aurobindo Pharma look good at current level.
Rakesh Bansal of RK Global recommends holding Granules India as the stock may test Rs 200 and advises buying Zee Media Corporation at the current level.
According to Jay Thakkar of ShareKhan, one may buy Adani Ports with a target of Rs 332-334
Rakesh Bansal of RK Global recommends buying Ceat with a target of Rs 1325 and DLF with a target of Rs 140.
CA Rudramurthy BV of Vachana Investments advises buying State Bank of India with a target of Rs 234.
Jay Thakkar of Sharekhan advises buying MphasiS with a target of Rs 444.
Devang Mehta of Anand Rathi Financial Services likes Sun Pharma, Granules India and Suven Lifesciences.
Devang Mehta of Anand Rathi Financial Services is of the view that one can buy Suven Life Sciences and Granules India.
According to Basant Maheshwari, founder, The Equity Desk one should look at sectors where there is degree of predictability. He recommends looking at pharma and intellectual property rights (IP) space.
Devang Mehta of Anand Rathi Financial Services prefers Suven Life Sciences and Granules India.
Devang Mehta of Anand Rathi Financial Services is of the view that Sun Pharma and Lupin still remains the top picks.
Here are top 10 stocks to focus on March 17 - HCL Technologies, Jet Airways, Dr Reddys, Hindustan Unilever (HUL), HDFC Bank, Bank of Baroda, Amtek Auto, Indian Hotel, BHEL and Zee Media.
Devang Mehta of Anand Rathi Financial Services is of the view that one may prefer Suven Life Sciences, Sun Pharma and Granules India.
Devang Mehta of Anand Rathi Financial Services is of the view that Granules India may test Rs 1000.
AK Prabharkar, Independent Advisor is of the view that one may sell Biocon with a target of Rs 392 and Indiabulls Real Estate with a target of Rs 51.50.
Pankaj Jain of Sunteck Wealthmax recommends buying Financial Technologies for a target of Rs 411 and Tata Elxsi for a target of Rs 634.
Dharmesh Kant of Indianivesh Securities recommends buying YES Bank with a stoploss at Rs 336 and Granules India for a target of Rs 310.
Dharmesh Kant, Indianivesh Securities advises buying Arvind for a target price of Rs 165 and Federal Bank for a target price of Rs 90.
Vishal Malkan, Malkansview advises buying Cox & Kings for a target price of Rs 158 and Bata India for a target price of Rs 1120.